{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:36:18Z","timestamp":1782869778063,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Coxsackievirus A6 (CVA6) is recognized as a major enterovirus type that can cause severe hand, foot, and mouth disease and spread widely among children. Vaccines and antiviral drugs may be developed more effectively based on a stable and easy-to-operate CVA6 mouse infection model. In this study, a wild CVA6-W strain was sub-cultured in newborn mice of different ages (in days), for adaptation. Therefore, a CVA6-A mouse-adapted strain capable of stably infecting the mice was generated, and a fatal model was built. As the result indicated, CVA6-A could infect the 10-day-old mice to generate higher levels of IFN-\u03b3, IL-6, and IL-10. The mice infected with CVA6-A were treated with IFN-\u03b11b at a higher dose, with complete protection. Based on this strain, an animal model with active immunization was built to evaluate antiviral protection by active immunization. The three-day-old mice were pre-immunized with inactivated CVA6 thereby generating IgM and IgG antibodies within 7 days that enabled complete protection of the pre-immunized mice following the CVA6 virus challenge. There were eight mutations in the genome of CVA6-A than in that of CVA6-W, possibly attributed to the virulence of CVA6 in mice. Briefly, the CVA6 infection model of the 10-day-old mice built herein, may serve as an applicable preclinical evaluation model for CVA6 antiviral drugs and vaccine study.<\/jats:p>","DOI":"10.3389\/fimmu.2021.665197","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T07:10:41Z","timestamp":1620889841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs"],"prefix":"10.3389","volume":"12","author":[{"given":"Zaixue","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqiu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baimao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"B1","article-title":"Hand-Foot-and-Mouth Disease: Rapid Evidence Review","volume":"100","author":"Saguil","year":"2019","journal-title":"Rev Am Fam Phys"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12250-019-00169-2","article-title":"National Epidemiology and Evolutionary History of Four Hand, Foot and Mouth Disease-Related Enteroviruses in China From 2008 to 2016","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0188640","DOI":"10.1371\/journal.pone.0188640","article-title":"Epidemiological and Genetic Characteristics of EV71 in Hand, Foot, and Mouth Disease in Guangxi, Southern China, From 2010 to 2015","volume":"12","author":"Chen","year":"2017","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12879-018-3624-5","article-title":"Epidemic Pattern of Hand-Foot-and-Mouth Disease in Xi\u2019an, China From 2008 Through 2015","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B5","article-title":"Hand-Foot-and-Mouth Disease Caused by Coxsackievirus A6 on the Rise","volume":"102","author":"Kimmis","year":"2018","journal-title":"Cutis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12887-018-1253-1","article-title":"An Outbreak of Coxsackievirus A6-Associated Hand, Foot, and Mouth Disease in a Kindergarten in Beijing in 2015","volume":"18","author":"Li","year":"2018","journal-title":"BMC Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2018.11.003","article-title":"Severe Atypical Hand-Foot-and-Mouth Disease in Adults Due to Coxsackievirus A6: Clinical Presentation and Phylogenesis of CV-A6 Strains","volume":"110","author":"Broccolo","year":"2019","journal-title":"J Clin Virol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01257-17","article-title":"A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles","volume":"92","author":"Chen","year":"2018","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2853","article-title":"Atypical Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6 in Denmark","volume":"98","author":"Horsten","year":"2018","journal-title":"A Diagn Mimicker"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000334619","article-title":"Clinical Features and Management Outcomes of Severe Hand, Foot and Mouth Disease","volume":"21","author":"Tian","year":"2012","journal-title":"Med Princ Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.04.003","article-title":"Susceptibilities of Enterovirus D68, Enterovirus 71, and Rhinovirus 87 Strains to Various Antiviral Compounds","volume":"131","author":"Smee","year":"2016","journal-title":"Antiviral Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0094-1","article-title":"A Virus-Like Particle-Based Tetravalent Vaccine for Hand, Foot, and Mouth Disease Elicits Broad and Balanced Protective Immunity","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/504563","article-title":"A Laboratory Evaluation of Medicinal Herbs Used in China for the Treatment of Hand, Foot, and Mouth Disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-21-31","article-title":"Animal Models of Enterovirus 71 Infection: Applications and Limitations","volume":"21","author":"Wang","year":"2014","journal-title":"Rev J BioMed Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e30507","DOI":"10.1371\/journal.pone.0030507","article-title":"Human SCARB2-mediated Entry and Endocytosis of EV71","volume":"7","author":"Lin","year":"2012","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00183-19","article-title":"A Novel Murine Model Expressing a Chimeric Mscarb2\/Hscarb2 Receptor is Highly Susceptible to Oral Infection With Clinical Isolates of Enterovirus 71","volume":"93","author":"Yang","year":"2019","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02450-16","article-title":"A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.06.008","article-title":"A Neonatal Mouse Model of Coxsackievirus A10 Infection for Anti-Viral Evaluation","volume":"144","author":"Li","year":"2017","journal-title":"Antiviral Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2019.1673135","article-title":"A Neonatal Murine Model of Coxsackievirus A4 Infection for Evaluation of Vaccines and Antiviral Drugs","volume":"8","author":"Zhang","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-019-04418-3","article-title":"Intranasal Immunization With Coxsackievirus A16 Virus-Like Particles Confers Protection Against Lethal Infection in Neonatal Mice","volume":"164","author":"Chen","year":"2019","journal-title":"Arch Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"Muench H. Simple Method of Estimating 50 Percent End-Points","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/01480548109018136","article-title":"A Computer Program for Estimating LD50 and its Confidence Limits Using Modified Behrens-Reed-Muench Cumulant Method","volume":"4","author":"Thakur","year":"1981","journal-title":"Drug Chem Toxicol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.06.008","article-title":"Application of Mouse Model for Effective Evaluation of Foot-and-Mouth Disease Vaccine","volume":"34","author":"Lee","year":"2016","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00902-12","article-title":"A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41426-018-0186-y","article-title":"A Neonatal Mouse Model of Central Nervous System Infections Caused by Coxsackievirus B5","volume":"7","author":"Mao","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/v7072803","article-title":"Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine","volume":"7","author":"Li","year":"2015","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/v10020058","article-title":"A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine","volume":"10","author":"Zhang","year":"2018","journal-title":"Viruses"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3680","article-title":"Protective Effect of enterovirus-71 (EV71) Virus-Like Particle Vaccine Against Lethal EV71 Infection in a Neonatal Mouse Model","volume":"12","author":"Cao","year":"2105","journal-title":"Mol Med Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99411","article-title":"Human tryptophanyl-tRNA Synthetase is an IFN-\u03b3-Inducible Entry Factor for Enterovirus","volume":"128","author":"Yeung","year":"2018","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.12.011","article-title":"Update on Hand-Foot-and-Mouth Disease","volume":"33","author":"Ventarola","year":"2015","journal-title":"Clin Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2018.07.013","article-title":"Discovery of a CLN7 Model of Batten Disease in non-Human Primates","volume":"119","author":"McBride","year":"2018","journal-title":"Neurobiol Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/1567205015666180904150118","article-title":"Alzheimer\u2019s Disease-Like Pathologies and Cognitive Impairments Induced by Formaldehyde in Non-Human Primates","volume":"15","author":"Zhai","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12985-020-01328-8","article-title":"Immunization With a Fusion Protein Vaccine Candidate Generated From Truncated Peptides of Human Enterovirus 71 Protects Mice From Lethal Enterovirus 71 Infections","volume":"17","author":"Liu","year":"2020","journal-title":"Virol J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.065","article-title":"A Novel Combined Vaccine Based on Monochimeric VLP Co-Displaying Multiple Conserved Epitopes Against Enterovirus 71 and Varicella-Zoster Virus","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.101","article-title":"Hepatitis B Virus Core Particles Containing Multiple Epitopes Confer Protection Against Enterovirus 71 and Coxsackievirus A16 Infection in Mice","volume":"35","author":"Huo","year":"2017","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e29751","DOI":"10.1371\/journal.pone.0029751","article-title":"Characterization of an Isotype-Dependent Monoclonal Antibody Against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection","volume":"7","author":"Lim","year":"2012","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1711678","article-title":"Short-Term Dynamic Changes in Neutralizing Antibodies Against Enterovirus 71 After Vaccination","volume":"16","author":"Wang","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.antiviral.2016.11.008","article-title":"Clinically Isolated Enterovirus A71 Subgenogroup C4 Strain With Lethal Pathogenicity in 14-Day-Old Mice and the Application as an EV-A71 Mouse Infection Model","volume":"137","author":"Xu","year":"2017","journal-title":"Antiviral Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-014-1035-2","article-title":"A Novel Finding for Enterovirus Virulence From the Capsid Protein VP1 of EV71 Circulating in Mainland China","volume":"48","author":"Liu","year":"2014","journal-title":"Virus Genes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25081","article-title":"Sequence Analysis-Based Characterization and Identification of Neurovirulence-Associated Variants of 36 EV71 Strains From China","volume":"90","author":"Xu","year":"2018","journal-title":"J Med Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3201\/eid2404.171298","article-title":"Emerging Coxsackievirus A6 Causing Hand, Foot and Mouth Disease, Vietnam","volume":"24","author":"Anh","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.104054","article-title":"Clinical Features and Phylogenetic Analysis of Severe Hand-Foot-and-Mouth Disease Caused by Coxsackievirus A6","volume":"77","author":"Yang","year":"2020","journal-title":"Infect Genet Evol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.chom.2018.03.019","article-title":"Kremen1 Is a Host Entry Receptor for a Major Group of Enteroviruses","volume":"23","author":"Staring","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13936-2","article-title":"Hand-Foot-and-Mouth Disease Virus Receptor KREMEN1 Binds the Canyon of Coxsackie Virus A10","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000619","article-title":"Molecular Epidemiology and the Evolution of Human Coxsackievirus A6","volume":"97","author":"Puenpa","year":"2016","journal-title":"J Gen Virol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25250","article-title":"Molecular Epidemiology of Coxsackievirus A6 Derived From Hand, Foot, and Mouth Disease in Fukuoka Between 2013 and 2017","volume":"90","author":"Yoshitomi","year":"2018","journal-title":"J Med Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1038\/s41598-017-05618-0","article-title":"Persistent Circulation of Coxsackievirus A6 of Genotype D3 in Mainland of China Between 2008 and 2015","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41467-017-00477-9","article-title":"Atomic Structures of Coxsackievirus A6 and its Complex With a Neutralizing Antibody","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/v7112916","article-title":"Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine Against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice","volume":"7","author":"Caine","year":"2015","journal-title":"Viruses"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.665197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T07:10:44Z","timestamp":1620889844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.665197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2021.665197"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.665197","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"article-number":"665197"}}